Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation
Clinical trial NCT01455051 · COMPLETED
Trial details
- NCT number
- NCT01455051
- Sponsor
- Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.